The Medicinal Chemist Role in the World of AI

Over the last few decades, the field of medicinal chemistry has been significantly changed by major innovations such as the internet and, more recently, automation. These changes have all driven the area towards quicker and more cost-effective medicinal chemistry, focused...

3 weeks ago
R&D,AI & ML,Biology,News

The Medicinal Chemist Role in the World of AI

Over the last few decades, the field of medicinal chemistry has been significantly changed by major innovations such as the internet and, more recently, automation. These changes have all driven the area towards quicker and more cost-effective medicinal chemistry, focused...

3 weeks ago

Weekly News Round-up – 13/3/20

Despite coronavirus’ new pandemic status and the number of new cases tied with Biogen’s conference in late February, today’s news really won’t discuss coronavirus, apart from this first sentence. In the news this week, among other things the UK’s latest...

3 months ago
Biology

Weekly News Round-up – 13/3/20

Despite coronavirus’ new pandemic status and the number of new cases tied with Biogen’s conference in late February, today’s news really won’t discuss coronavirus, apart from this first sentence. In the news this week, among other things the UK’s latest...

3 months ago

R&D: The Impact of AI in 2020

Whenever Proventa holds a Strategy Meeting around the world - regardless of meeting topic - the subject of AI comes up. It really is so important in pharma right now, with the potential to solve some of the sector's big...

3 months ago
Oncology,R&D,Bioinformatics,Biology,News

R&D: The Impact of AI in 2020

Whenever Proventa holds a Strategy Meeting around the world - regardless of meeting topic - the subject of AI comes up. It really is so important in pharma right now, with the potential to solve some of the sector's big...

3 months ago

Weekly News Round-up – 14/2/20

The U.S. Institute for Clinical and Economic Review’s (ICER’s) methods could see legal challenges in the near future, a think tank has warned, due to discrimination against disabled individuals. In other news, Novartis’ rare lung cancer drug capmatinib will be...

3 months ago
Oncology,Bioprocess,Clinical Development,Weekly Roundups,Biology

Weekly News Round-up – 14/2/20

The U.S. Institute for Clinical and Economic Review’s (ICER’s) methods could see legal challenges in the near future, a think tank has warned, due to discrimination against disabled individuals. In other news, Novartis’ rare lung cancer drug capmatinib will be...

3 months ago

The Changing Role of the Blockbuster Drug

There are few pharmaceutical companies not seeking the next big "blockbuster", a market drug earning revenue over $1 billion. These big-name products, which include Keytruda and Lipitor, are well-marketed and broadly-effective, often across several illnesses. For years scientists have worked...

4 months ago
Oncology,R&D,Biology,News

The Changing Role of the Blockbuster Drug

There are few pharmaceutical companies not seeking the next big "blockbuster", a market drug earning revenue over $1 billion. These big-name products, which include Keytruda and Lipitor, are well-marketed and broadly-effective, often across several illnesses. For years scientists have worked...

4 months ago

How Can We Speed up Vaccine R&D?

With the rapid spread of the coronavirus 2019-nCoV through China and now globally, governments and organisations have implemented a range of preventative measures. Chinese provinces including Beijing and Shanghai have shut down long-distance bus services and entirely closed off some...

4 months ago
R&D,Biology,News

How Can We Speed up Vaccine R&D?

With the rapid spread of the coronavirus 2019-nCoV through China and now globally, governments and organisations have implemented a range of preventative measures. Chinese provinces including Beijing and Shanghai have shut down long-distance bus services and entirely closed off some...

4 months ago

Antibiotic Resistance: Is Pharma Doing Enough?

Developed resistances to certain antibiotics have occurred since their creation in the 1940s. Scientists found the first case of resistance just four years after antibiotics entered mass production. Only recently, however, has the issue taken a critical turn. Resistant strains of...

4 months ago
R&D,Pharmacovigilance,Biology

Antibiotic Resistance: Is Pharma Doing Enough?

Developed resistances to certain antibiotics have occurred since their creation in the 1940s. Scientists found the first case of resistance just four years after antibiotics entered mass production. Only recently, however, has the issue taken a critical turn. Resistant strains of...

4 months ago

Weekly News Round-up – 17/1/20

The week passed fairly uneventfully this time, with the baffling politics and shocking events of the new decade struggling to get started. Instead, research from Scottish universities indicated a link between a type of common gut bacteria and Parkinson's; a...

4 months ago
Oncology,Weekly Roundups,Biology

Weekly News Round-up – 17/1/20

The week passed fairly uneventfully this time, with the baffling politics and shocking events of the new decade struggling to get started. Instead, research from Scottish universities indicated a link between a type of common gut bacteria and Parkinson's; a...

4 months ago

The Future of Organ-on-a-Chip

Dozens of solutions have been suggested to lessen the crisis that has been hitting pharma R&D recently. Over the last decade, the cost of creating drugs has skyrocketed even as the amount of new medicines reaching market is steadily declining....

5 months ago
Oncology,R&D,Biology,News

The Future of Organ-on-a-Chip

Dozens of solutions have been suggested to lessen the crisis that has been hitting pharma R&D recently. Over the last decade, the cost of creating drugs has skyrocketed even as the amount of new medicines reaching market is steadily declining....

5 months ago

Cancer Drugs Could be Hitting Wrong Targets

Current cancer drugs may be hitting the wrong protein targets, a study has found, giving a possible explanation for the low success rates of those drugs during their early stages.  The study, recently published in Science Translational Medicine journal and...

9 months ago
Oncology,Biology,News

Cancer Drugs Could be Hitting Wrong Targets

Current cancer drugs may be hitting the wrong protein targets, a study has found, giving a possible explanation for the low success rates of those drugs during their early stages.  The study, recently published in Science Translational Medicine journal and...

9 months ago